Clinical Trial

The Role of Melatonin as an Adjuvant Therapy in Childhood Pneumonia

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated April 29, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to compare the mean length of hospital stay between children with pneumonia receiving melatonin as an adjuvant therapy and those receiving standard of care alone. The hypothesis is that combining oral melatonin with standard treatment can reduce the length of hospital stay as compared to standard of care alone. The control group will receive standard treatment (antibiotic) while the intervention group will receive standard treatment plus melatonin for 14 days.
Trial Details
NCT Number NCT06949904
Lead Sponsor Mian Muhammad Hassan Ahmed
Conditions Pneumonia Childhood
Enrollment 60 participants
Start Date 2025-05
Primary Completion 2025-12 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-29